Yunhong Green CTI (YHGJ) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
12 Nov, 2026Executive summary
Annual meeting scheduled for Dec. 30, 2026; record date Nov. 2, 2026. Proposals cover six director elections, advisory executive-pay votes and auditor ratification.
Board recommends votes FOR all six nominees, executive compensation and Wolf & Company, and a three-year interval for future say-on-pay votes.
Voting matters and shareholder proposals
Each director nominee requires a majority of votes represented and entitled to vote; abstentions count against, while broker non-votes have no effect.
Say-on-pay requires a majority vote; the frequency receiving the most votes prevails. The Board favors three years; if selected, the next vote would be in 2029.
Wolf & Company’s appointment for FY2027 requires majority approval; brokers may vote without instructions, and the Audit Committee will reconsider the appointment if shareholders reject it.
Rule 14a-8 proposals for the expected December 2027 meeting are due by July 19, 2027; other business and director nomination notices are due June 19–July 19, 2027.
Board of directors and corporate governance
Six incumbent directors are nominated for one-year terms through the 2027 annual meeting; five of six directors are Nasdaq-independent, and independent directors chair and comprise all committees.
Fred Chak became director in March 2026 and Board chair in April; Iris Chan joined in January 2026 and chairs Audit. The Board has not designated a lead independent director since January 2026.
The Board met 14 times in 2025; each then-serving director attended at least 75% of applicable Board and committee meetings.
The Nominating and Governance Committee adopted its charter Nov. 12, 2026, and recommended the six incumbent nominees; it considers business experience, integrity, reputation and diversity of background and experience.
Latest events from Yunhong Green CTI
- Q2 2026 sales dropped 29% with a net loss and ongoing going concern risks due to liquidity.YHGJ
Q2 2026 - Q1 2026 sales grew 28% but losses and liquidity issues raise going concern doubts.YHGJ
Q1 2026 - Net sales rose 10% but net loss deepened to $2.7M, with ongoing liquidity and concentration risks.YHGJ
Q4 2025 - Key votes include director elections, a reverse stock split, and auditor ratification.YHGJ
Proxy Filing - Key votes on director elections, reverse stock split, and auditor ratification highlight governance focus.YHGJ
Proxy Filing - Annual meeting to elect directors, ratify auditors, and address governance and compensation.YHGJ
Proxy Filing - Sales growth and margin improvement offset by ongoing liquidity and going concern risks.YHGJ
Q3 2025 - Q2 2025 saw higher sales and improved margins, but liquidity and going concern risks remain.YHGJ
Q2 2025 - Net sales grew 7% in Q2, but losses and liquidity risks persist amid high customer concentration.YHGJ
Q2 2024